Pittman Scott M.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bluefield, WV
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David Jorden, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Pittman Scott M.

Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Capital Initial Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Capital Second Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Commitment Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Origination Initial Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Origination Second Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Prepayment Warrants (right to buy)
Shares / value
0
Estimated value
$0
Report date
23 Jan 2026
Price
$1.50
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Initial Warrant (right to buy)
Shares / value
30,050
Estimated value
Report date
23 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Option to purchase common stock
Shares / value
30,000
Estimated value
Report date
29 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Interim Warrant (right to buy)
Shares / value
17,450
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Prepayment Restated Warrant (right to buy)
Shares / value
0
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Prepayment Warrant (right to buy)
Shares / value
0
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Second Restated Warrant (right to buy)
Shares / value
0
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Nuo Therapeutics, Inc.

Security class
Second Warrant (right to buy)
Shares / value
0
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Pittman Scott M.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .